Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Myelodysplastic Syndromes 42Leukemia, Myeloid, Acute 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia 20Lymphoma, Non-Hodgkin 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Hodgkin Disease 11Leukemia, Myelomonocytic, Chronic 10Multiple Myeloma 6Lymphoma 6Leukemia, Myelomonocytic, Juvenile 6Leukemia, Lymphocytic, Chronic, B-Cell 6Leukemia, Myeloid, Accelerated Phase 5Congenital Abnormalities 5Anemia, Refractory, with Excess of Blasts 5Recurrence 4Leukemia, Biphenotypic, Acute 4Blast Crisis 4Primary Myelofibrosis 3Neoplasms 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Promyelocytic, Acute 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Hematologic Neoplasms 3Graft vs Host Disease 3Lymphoma, Mantle-Cell 2

Interventions

X-Rays 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Flow Cytometry 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Biopsy 5Therapeutics 4Methylprednisolone 4Cyclophosphamide 4Radiotherapy 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Immunologic Techniques 3Antilymphocyte Serum 3Amplified Fragment Length Polymorphism Analysis 3ulixertinib 2trametinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2liposomal amphotericin B 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2dabrafenib 2Voriconazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Clofarabine × Myeloid × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡